Jernej Godec

We are proud to announce the closing of Atlas Venture Fund XIV today, our newest early-stage fund to enable the creation and support of new biotech companies working to bring new medicines to patients. Learn more here: businesswire.com/news/home/2024…

Mariana Oncology’s Radiopharm Platform Acquired By Novartis It's always about people. This M&A reinforces the axiom in venture that backing great teams is critical to success, and a big part of that is leveraging deep relationships across the ecosystem lifescivc.com/2024/05/marian…

I ask for your help to support this Turkey Earthquake Fund gofundme.com/f/xh8d5t-turke… that will directly help affected families in the region. Thanks everyone who reached out during these difficult times, truly appreciate and will never forget your support ❤️ Please share this 🙏

Here’s the Atlas Venture 2022 Year In Review. This year, given the 2+ year rollercoaster in the mkts, we start with a deep dive into both the public and private #biotech capital markets, then to the industry overall, closing with an update on ⁦Atlas youtu.be/LONM9ekseJ4

#Science2Startup is an opportunity for #lifescience researchers to showcase their startup ideas and network with top #biotech and #pharma execs, VCs and entrepreneurs in the Boston area. Applications are due December 5, 2022 - submit your idea today! science2startup.com

Atlas Venture 2021 Year In Review Here's our "state of the industry" talk (that we just shared with our LP's at our Annual Meeting) exploring the macro issues & broader sector, diving into the biotech VC ecosystem, and providing a brief update on Atlas. youtu.be/Es1wzWnED-g

We are proud to announce Atlas Venture Opportunity Fund II, a $300M fund dedicated to supporting our breakthrough portfolio biotech companies bwnews.pr/39VZltU

Congratulations Versanis Bio, announcing $70M in Series A financing to advance bimagrumab into an advanced Phase 2 program for the treatment of obesity. We are proud to partner with Aditum Bio, @medicxi, and the fantastic team @VersanisBio! businesswire.com/news/home/2021…

“B cells have been such an attractive cell type,” said Aleks Radovic-Moreno, who co-founded Be Biopharma. “It just wasn’t their time yet. But now we feel confident that it’s their time to step into the limelight.” endpts.com/can-b-cells-br…

Calling all academic researchers with innovative therapeutic startup ideas! Submit your proposal to #Science2Startup to present to an audience of top biopharma investors, executives, and researchers. Submissions are due November 1 here: science2startup.com

@ElstarTx @loewan I really hope that’s not actually Andreas’ secret twitter handle... way too much on his plate these days to be living a double life this whole time too!

@nickhaining @DanaFarber Remember when the lab was small enough that we had lab meetings in that office?? Good memories there...

Leaving my office after my last day at the great ⁦@DanaFarber⁩ So long, and thanks for all the fish.

@nickhaining You have left me with the same curse and I can’t get away from it!! @SENGLAITAN @ElstarTx @caincw @ablT315I - perhaps this explains a thing or two on my PPT OCD-ness..

My job here is done.

So, a spot of news: delighted to say I’ll be starting as VP, Oncology @Merck in Jan. Very sad to leave phenomenal colleagues and trainees @DanaFarber & @BroadInstitute yet thrilled to be leading a world-class team discovering medicines for the people who need them most.

Akero Therapeutics today announces that Andrew Cheng, MD, PhD, former CMO of Gilead Sciences, has joined as President and CEO of @akerotx to advance new therapies for serious metabolic diseases. Welcome Andrew! We are thrilled to have you! ow.ly/Aj1E30lLPMi

@ElstarTx @MonstahTruck This is what you guys do when I am not there?! :D

FDA has assigned a December 26 goal date for our Fast Track and Priority Review NDA for CAM2038 Weekly & Monthly injectable. CAM2038 represents a potential game-changing treatment for #OpioidUseDisorder. cards.twitter.com/cards/18ce54q9…

Today marks the launch of @AkeroTx working to transform the treatment of non-alcoholic steatohepatitis, or NASH, and other serious metabolic diseases. #NASH ow.ly/yjNX30kEbP4

Sometimes, its good to have Skin in the Game. I wanted to share our latest article on reimbursements for all doctors, especially dermatologists! goo.gl/DAKDcw @JAADjournals @AMostaghimi #highvaluecare #dermatology #skininthegame #paymentmodels

so excited to have had the opportunity to write about easy ways to make improve dermatology practice - jaad.org/article/S0190-…. #highvaluecare #evidencebaseddermatology #dermatology #medicaldermatology